期刊文献+

膀胱移行细胞癌术后复发的相关因素分析 被引量:3

Analysis of related factors in recurrence of bladder transitional cell carcinoma
下载PDF
导出
摘要 目的探讨膀胱移行细胞癌手术后复发与相关因素的关系,并评估预后。方法总结1999~2004年收治的140例膀胱癌手术后的复发情况并进行统计学分析。结果膀胱癌手术后复发与肿瘤位置,数目,大小,手术方式,病理分级有显著相关性,其中肿瘤数目与复发有极显著的相关性。肿瘤数目与复发有统计学意义。结论多发、病理分级较高、肿瘤直径大于3cm以及位于膀胱颈周围的肿瘤更容易复发,预后较差,应高度重视。多发肿瘤与复发最重要。 Objective To study the recurrence related factors and to evaluate prognosis in patients with bladder cancer. Methods we retrospectively review and analyze 140 patients with bladder cancer between 1999 and the end of 2004, The statistical analysis was done. Results The K-square test was used in the relatively analysis between mono factor and recurrence. The most important factor is tumor number, and other factors are not statistically significant. Conclusions Tumor number is the most important factor in the prognosis of bladder cancer, tumor's grade, size, site need to be paid more attention as well.
出处 《北京医学》 CAS 2007年第11期678-680,共3页 Beijing Medical Journal
关键词 膀胱癌 预后 复发 Bladder cancer Prognosis Recurrence
  • 相关文献

参考文献7

  • 1葛宏发.泌尿外科学常见疾病诊断及鉴别诊断.第2版.北京:人民卫生出版社,2002:319-322.
  • 2林云华,金杰,薛兆英,那彦群,郭应禄.p53,p21/WAF1,pRb的表达与T_1G_3膀胱癌预后的关系[J].中华泌尿外科杂志,2002,23(9):562-564. 被引量:6
  • 3张军,曾荔,李贵忠,杨新宇,夏同礼,那彦群,郭应禄.膀胱移行细胞癌T1期复发的多因素分析[J].中华肿瘤杂志,2003,25(5):475-477. 被引量:18
  • 4Andres RA,Salvador PF,Joaquin GG,et al.Multivariate analysis of survival,recurrence,progression and development of metastasis in T1 and T2a Transitional Cell Bladder Carcinoma.Cancer,2002,94:1677-1684.
  • 5Redriguez-Alonso A,Pita-Fernandez S,Gonzalez-Carrero J,et al.Multivariate analysis of survival,recurrence,progression and de-velopmcnt of metastasis in T1 and T2a transitional cell bladder carcino-ma.Cancer,2002,94:1677-1684.
  • 6Denkbas EB,Zdemyr N,zturk E.Mitomycin-C-loaded alginatecarriers for bladder cancer chemotherapy.Bioaet Compat Polym,2004,19:33-44.
  • 7Morgan JOT,Bowsher W,Griffiths DFR,et al.Rationalisation of follow2up in patients with non2invasive bladder tumors.Br J Urol,1991,67:158.

二级参考文献11

  • 1Serth J, Kuczyk MA, Bokemeyer C, et al. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer, 1995. 71 : 201-205.
  • 2Lipponen PK, Eskelinen MJ. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol, 1995, 121 : 303-306.
  • 3Shariat SF, Pahlavan S, Baseman AG, et al. E-cadlherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder.Urology, 2001, 57: 60-65.
  • 4Zhang HT, Craft P, Scott PA, etal. Enhancement of tumor growth and vascularity by transfection of vascular endothelial growth factor into MCF-7 cells breast carcinoma cells. J Nail Cancer Inst, 1995, 87: 213-219.
  • 5Chow NH, Liu HS, Chan SH, et al. Expression of vascular endolhelial growth factor in primary superficial bladder cancer. Anticancer Res,1999. 19: 4593-4597.
  • 6Pycha A, Mian C, Hoibauer J, et al. Multifocality of transitional cellcarcinoma results from genetic instability of entire transitional epithelium.Urology, 1999, 53: 92-97.
  • 7Andres RA, Salvador PF, Joaquin GG, et al. Multivariate analysis of survival recurrence progression and development d metastasis in T1 andT2a Transitional Cell Bladder Carcinoma. Cancer, 2002.94: 1677-1684.
  • 8Allard P, Bemard P, Frader Y, et al. The early clinical course of primary Ta and T1 bladder cancer : a proposed prognostic indet. Br J Urol, 1998, 81: 692-698.
  • 9Holmang S, Hedelin H, Anderstrom C, et al. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol, 1995, 153: 1823-1827.
  • 10Brausi M, Collette L, Kxulh K, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol, 2002, 41 : 523-531.

共引文献22

同被引文献30

  • 1胡志红,程玲,吴萍,龚勇,黄征,郑美荣.CK34_βE12、p63和p504S联合检测在前列腺肿瘤鉴别诊断中的应用[J].诊断病理学杂志,2005,12(2):123-125. 被引量:20
  • 2赵凯亮,胡云飞.膀胱移行细胞癌预后因素分析[J].临床外科杂志,2009,17(11). 被引量:4
  • 3邱国光,雷德利.膀胱移行细胞癌微血管密度与其复发的关系[J].实用医技杂志,2007,14(14):1836-1838. 被引量:5
  • 4吴阶平.吴阶平泌尿外科学[M].济南:山东科学技术出版社,2008:991-1010.
  • 5Campbell SC, Volpert OV, Ivanovich M, et al. Molecular mediators of angiogenesis in bladder cancer[J].Cancer Res, 1998, 58(6) : 1298-1304.
  • 6Dawson DW, VolpertOV, Gillis P, et al. Pigment epithelium-derived factor:a potent inhibitor of angiogenesis[J]. Science, 1999,285(3425) :245-248.
  • 7Chang SY, Yud S, Wang J, et al. Histopathologieal effects and recovery rate of rat bladders following intravesical instillation of thiotepa, doxorubicin and mitomycin C[J]. Br J Urol, 1990, 66(6) : 623-627.
  • 8Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity[J]. Exp Eye Res, 1991,53(3) : 411-414.
  • 9Guan M, Yam HF, Su B, et al. Loss of pigment epithelium derived factor expression in glioma progression[J]. J Clin pathol, 2003,56 (4) : 277-282.
  • 10陈合群,祖雄兵,陈志勇,江锋,齐琳.几个影响膀胱移行细胞癌复发因素的临床分析[J].临床泌尿外科杂志,2007,22(8):608-609. 被引量:6

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部